TaiJi

太极药业

Taiji Group Co., Ltd. is a cross-regional, cross-industry large state-owned enterprise group in China, focusing primarily on both Chinese and Western medicine, rooted in natural drug development, and involved in cutting-edge areas such as chemical pharmaceuticals, biopharmaceuticals, stem cell engineering, and nanotechnology. With health food products as a secondary business, it is also involved in packaging, transportation, and services as supporting industries. Taiji Group is one of the 520 large enterprises determined by China’s National Economic and Trade Commission and one of the 30 enterprises in Chongqing that are key to expansion. It currently owns three publicly listed companies: Chongqing Taiji Industry (Group) Co., Ltd., Chongqing Tongjunge Co., Ltd., and Southwest Pharmaceuticals Co., Ltd., and has 54 independent legal entities under its umbrella.

In August 2016, Taiji Group ranked 390th in the “2016 Top 500 Chinese Enterprises”. On September 1, 2019, the 2019 Top 500 Chinese Manufacturing Enterprises list was released, with Taiji Group Co., Ltd. ranking 180th. On December 13, 2019, the 2019 Chongqing Top 100 Enterprises list was released, and Taiji Group Co., Ltd. ranked 14th.

Taiji Group Co., Ltd. is one of the top 500 enterprises in China, with assets of 160 billion yuan. It owns three listed companies: “Taiji Group”, “Tongjunge”, and “Southwest Pharmaceuticals”, with over 6,000 large pharmacies, 13,000 employees, nine pharmaceutical factories, and over 20 commercial companies, making it the most comprehensive large enterprise group in China’s pharmaceutical industry chain. Today, “Taiji” (TAIJI) has become a well-known trademark in China. In 2009, the group’s total sales reached 130 billion yuan. Former party and national leaders such as Wen Jiabao, Jiang Zemin, Li Peng, Wu Bangguo, Zeng Qinghong, and Zou Jiahua have visited Taiji Group many times, giving high praise.

Behind Taiji Group’s strong strength lies a robust research system composed of the Chongqing Traditional Chinese Medicine Research Institute, Taiji Medical Research Institute, post-doctoral research stations, and five major R&D centers. The company has developed a positive pattern of developing one generation of drugs, researching another, and stockpiling a third, with over 1,500 types of Chinese and Western medicines available. It has over 50 exclusively produced varieties in China, 108 national patents, over 30 varieties protected by national traditional medicine, and six varieties with an annual turnover of over 1 billion yuan. It owns renowned products like Agastache Rugosa Regulating Qi Oral Solution, Tailuo, Emergency Sugar Syrup, Er Kang Ning, Kidney-tonifying Life-extending Capsules, and Tomato Capsules, which have a significant reputation both domestically and internationally.

Taiji Group has transformed its production technology into productivity, resulting in qualitative leaps. It owns Asia’s largest syrup production line with an annual output of 100 million bottles; China’s largest oral solution production line with an annual output of 1 billion bottles; China’s largest workshop for the pretreatment and extraction of medicinal materials, with an annual output of 100,000 tons; China’s first GMP model workshop for lyophilized powder injection production; the world’s most advanced Japanese bottle production line, German soft bag large infusion production line, Canadian automatic pellet production line, and Italian fully automatic packaging line.

The Group uses “full staff marketing” as its trump card to rapidly expand its market share and sales network, with over 3,000 sales personnel, over 500 general agents, over 3,000 distributors, over 4,000 hospital pharmacies, and over 100,000 pharmacies. Its comprehensive marketing management has won it the honor of the “National Management Achievement First Prize” in 2000.

Its subsidiary, Tongjunge Co., Ltd., is the largest pharmaceutical commercial enterprise in western China, with the most comprehensive pharmaceutical commercial network in the west. It is the first chain company in China to pass the GSP certification, with over 6,000 pharmacies and over 1,500 village-level drug counters radiating to China’s retail market, operating more than 20,000 product specifications and over 600 high-quality products. Centered around the Chengdu Western Medicine Group, the Taiji pharmaceutical logistics system includes regional logistics centers in Chengdu and Chongqing and 14 southwestern distribution centers, making it the most developed pharmaceutical logistics system in western China. In 2008, “Tongjunge” celebrated its centennial, and in 2009, its commercial sales reached 90 billion yuan.

Best-selling Products from the Taiji Brand：